Vesicle Transport through Interaction with T-SNAREs Homolog 1B (VTI1B) Peptide
-
- Target See all VTI1B products
- VTI1B (Vesicle Transport through Interaction with T-SNAREs Homolog 1B (VTI1B))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- IERSHRIATE TDQIGSEIIE ELGEQRDQLE RTKSRLVNTS ENLSKSRKIL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of VTI1 B antibody,
Alternative Names: VTI1B control peptide, VTI1B antibody Blocking Peptide, Anti-VTI1B Blocking Peptide, vesicle transport through interaction with t-SNAREs homolog 1B, yeast Blocking Peptide, VTI1 Blocking Peptide, VTI1-LIKE Blocking Peptide, VTI1L Blocking Peptide, VTI2 Blocking Peptide, VTI1B, VTIB-1, VTIB 1, VTIB-1 Blocking Peptide, VTIB 1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- VTI1B (Vesicle Transport through Interaction with T-SNAREs Homolog 1B (VTI1B))
- Background
- V-SNARE that mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. It may be concerned with increased secretion of cytokines associated with cellular senescence.
- Molecular Weight
- 26 kDa
-